AACR Project GENIE: Participation
To learn about the individual contributors from each institution, visit our Participating Individuals page.
PARTICIPATING INSTITUTIONS
- Cancer Research UK Cambridge Centre, University of Cambridge, Cambridge, England
- Children’s Hospital of Los Angeles, California
- Children’s Hospital of Philadelphia Cancer Center, Philadelphia, Pennsylvania
- Dana-Farber Cancer Institute, Boston, Massachusetts*
- Duke University (Duke Cancer Institute), Durham, North Carolina
- Gustave Roussy Cancer Campus, Paris-Villejuif, France*
- Herbert Irving Comprehensive Cancer Center, Columbia University, New York, New York
- Korea University Anam Hospital
- Louisiana State University Health Sciences Center New Orleans
- The Netherlands Cancer Institute, Amsterdam, on behalf of the Center for Personalized Cancer Treatment, Utrecht, The Netherlands*
- Memorial Sloan Kettering Cancer Center, New York*
- Princess Margaret Cancer Centre, Toronto, Ontario, Canada*
- Providence Cancer Institute, Portland, Oregon
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland*
- Swedish Cancer Institute, Seattle, Washington
- University of California-San Francisco (UCSF Helen Diller Family Comprehensive Cancer Center), San Francisco, California
- University of Chicago Comprehensive Cancer Center, Chicago, Illinois
- University of Miami Sylvester Comprehensive Cancer Center
- Vanderbilt-Ingram Cancer Center, Nashville, Tennessee*
- Vall d’ Hebron Institute of Oncology, Barcelona, Spain
- Wake Forest University Health Sciences (Wake Forest Baptist Medical Center), Winston-Salem, North Carolina
- Yale University (Yale Cancer Center), New Haven, Connecticut
*founding members
Participating Institutions Requirements
- Provide 500 genomic records to start; 500 each subsequent year of participation: Data must be CLIA- or ISO-certified
- Limited Data sets as defined by 45 C.F.R. § 164.514(e) will be provided
- If de-identified datasets are provided, the process must adhere to the project’s established protocol
- Maintain IRB approval
- Meet data standards and deadlines
- Participate in meetings
- Participate in committees and subcommittees
- Execute the Master Participation Agreement and agree to all exhibits, including the Data User Agreement
- Past GENIE new participant applicants were judged based on these criteria: AACR Project GENIE Participation Evaluation Criteria
Informatics Partners
- Sage Bionetworks, Seattle, Washington
- cBioPortal, New York, New York
Criteria for Informatics Strategic Partners
- Significant prior experience in similar projects
- Secure, HIPAA-compliant infrastructure
- Established and accepted platforms
- Significant bioinformatics expertise
New Participating Institutions
- The open call for new participating institutions will begin on May 1st, 2022. Find more information about the 2022 GENIE New Participant Open call here.